Matches in Wikidata for { <http://www.wikidata.org/entity/Q83049556> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q83049556 description "artículu científicu espublizáu n'abril de 2006" @default.
- Q83049556 description "scientific article published on 01 April 2006" @default.
- Q83049556 description "wetenschappelijk artikel" @default.
- Q83049556 description "наукова стаття, опублікована у квітні 2006" @default.
- Q83049556 name "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 name "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 type Item @default.
- Q83049556 label "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 label "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 prefLabel "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 prefLabel "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 P1433 Q83049556-56BF0FA6-5E84-4C5C-82AC-18FB5131621B @default.
- Q83049556 P1476 Q83049556-9F4A8694-52A4-4782-8123-8489E4A69820 @default.
- Q83049556 P2093 Q83049556-051B0FF7-7EFC-4418-AED7-A0574A93B183 @default.
- Q83049556 P2093 Q83049556-13587A37-6BCA-4807-95B3-39CD22FC2A31 @default.
- Q83049556 P2093 Q83049556-38292312-D7B6-486B-9CE2-0E3D3F67768D @default.
- Q83049556 P2093 Q83049556-39915129-53FC-4F0B-8E16-011E37EBC944 @default.
- Q83049556 P2093 Q83049556-49505FF7-D4BA-4AF7-A710-8ECDCBBFF5D9 @default.
- Q83049556 P2093 Q83049556-8CED76A2-2A4A-4CE5-B817-FF419F0D1302 @default.
- Q83049556 P2093 Q83049556-9EE88567-9734-49E9-ABEC-72C1E8846A3A @default.
- Q83049556 P2093 Q83049556-CF24D725-F8B0-488D-8311-8D7AFF91B83C @default.
- Q83049556 P2093 Q83049556-F27DDABD-00E0-4F34-8FD0-6AA198797C09 @default.
- Q83049556 P2093 Q83049556-F9B4D68C-1E2E-4CAE-B4DD-39493BC42276 @default.
- Q83049556 P304 Q83049556-A7DA779E-DCD0-4145-A173-74AC6E90685A @default.
- Q83049556 P31 Q83049556-A43B4F2C-AADE-4822-A80E-E99323977197 @default.
- Q83049556 P407 Q83049556-8203C50D-5C46-475C-B33A-0561D85BA7BF @default.
- Q83049556 P433 Q83049556-7ED4C125-F063-4573-95F1-4889DD547024 @default.
- Q83049556 P478 Q83049556-4119EDAC-C009-4C9D-A63E-4757D11D0E5C @default.
- Q83049556 P50 Q83049556-8146A35D-4C9D-41A3-A339-E273FFAD6672 @default.
- Q83049556 P577 Q83049556-1C83F815-BE2F-4EEE-87D0-4C6E4B7D4B03 @default.
- Q83049556 P698 Q83049556-EF8E5283-9795-4111-B735-AD2A61FD48DA @default.
- Q83049556 P921 Q83049556-93DE4475-8FF7-4DC8-A8AF-0DD32B638D45 @default.
- Q83049556 P698 16583466 @default.
- Q83049556 P1433 Q7743623 @default.
- Q83049556 P1476 "A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis" @default.
- Q83049556 P2093 "Bart Van Hartingsveldt" @default.
- Q83049556 P2093 "Daniel E Everitt" @default.
- Q83049556 P2093 "Deborah Sisco" @default.
- Q83049556 P2093 "Esther Bouman-Thio" @default.
- Q83049556 P2093 "Frédéric Houssiau" @default.
- Q83049556 P2093 "Johan Joly" @default.
- Q83049556 P2093 "Martin A Graham" @default.
- Q83049556 P2093 "Mary Ann Mascelli" @default.
- Q83049556 P2093 "Patrick Durez" @default.
- Q83049556 P2093 "René Westhovens" @default.
- Q83049556 P304 "847-853" @default.
- Q83049556 P31 Q13442814 @default.
- Q83049556 P407 Q1860 @default.
- Q83049556 P433 "5" @default.
- Q83049556 P478 "33" @default.
- Q83049556 P50 Q63585148 @default.
- Q83049556 P577 "2006-04-01T00:00:00Z" @default.
- Q83049556 P698 "16583466" @default.
- Q83049556 P921 Q187255 @default.